These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12712482)
21. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. Ficarra V; Dalpiaz O; Alrabi N; Novara G; Galfano A; Artibani W BJU Int; 2005 Apr; 95(6):786-90. PubMed ID: 15794783 [TBL] [Abstract][Full Text] [Related]
22. [Carcinoma of the bladder in urogenital bilharziasis (author's transl)]. Wagenknecht LV Urologe A; 1974 Mar; 13(2):59-62. PubMed ID: 4832067 [No Abstract] [Full Text] [Related]
23. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877 [TBL] [Abstract][Full Text] [Related]
25. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year. Guney S; Guney N; Canogullari Z; Ergenekon E Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479 [TBL] [Abstract][Full Text] [Related]
26. Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Lieskovsky G; Quinn DI; Raghavan D; Skinner DG Cancer; 2003 Sep; 98(5):955-61. PubMed ID: 12942562 [TBL] [Abstract][Full Text] [Related]
27. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LL Cancer; 2007 Jul; 110(1):62-7. PubMed ID: 17542024 [TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Yang TB; Zeng FH; Sun ZQ Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
30. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635 [TBL] [Abstract][Full Text] [Related]
31. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Raman JD; Sosa RE; Vaughan ED; Scherr DS Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658 [TBL] [Abstract][Full Text] [Related]
32. High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature. Sanborn SL; MacLennan G; Cooney MM; Zhou M; Ponsky LE Urology; 2009 Apr; 73(4):928.e13-5. PubMed ID: 19056107 [TBL] [Abstract][Full Text] [Related]
33. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications]. Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580 [TBL] [Abstract][Full Text] [Related]
35. Transitional cell carcinoma of the bladder metastatic to the penis. Bordeau KP; Lynch DF Urology; 2004 May; 63(5):981-3. PubMed ID: 15134996 [TBL] [Abstract][Full Text] [Related]
36. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Scosyrev E; Yao J; Messing E Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403 [TBL] [Abstract][Full Text] [Related]
37. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Prout GR; Wesley MN; Yancik R; Ries LA; Havlik RJ; Edwards BK Cancer; 2005 Oct; 104(8):1638-47. PubMed ID: 16130136 [TBL] [Abstract][Full Text] [Related]
38. Bladder cancer in Sri Lanka: experience from a tertiary referral center. Goonewardena SA; De Silva WA; De Silva MV Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199 [TBL] [Abstract][Full Text] [Related]
39. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma. Granfors T; Tomic R; Ljungberg B Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744 [TBL] [Abstract][Full Text] [Related]